Search - tctmd.com

Displaying 401 - 420 of 807

Sort: Relevancy | Date

News Daily News

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

July 10, 2014

News Daily News

Patient Traits Predict Need for Permanent Pacemaker After TAVR

Yael L. Maxwell

July 10, 2014

News Daily News

Los Rasgos del Paciente Predicen la Necesidad de Implantación de un Marcapasos Permanente Post-TAVR

Yael L. Maxwell

July 10, 2014

Presentation

Predictors of Permanent Pacemaker in Patients with Severe Aortic Stenosis Undergoing TAVR

Presenter: G.C.M. Siontis

July 08, 2014

News Daily News

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

July 03, 2014

News Daily News

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

June 27, 2014

News Daily News

Sapien XT Given Go-Ahead to Make US Debut

Caitlin E. Cox

June 24, 2014

News Daily News

Sapien XT Aprobado; Hará su Aparición en EE.UU.

Caitlin E. Cox

June 24, 2014

News Daily News

CoreValve Approved for TAVR in High-Risk Patients

June 17, 2014

News Industry News

Edwards Lifesciences Launching SAPIEN XT Valve in the U.S.

June 16, 2014

News Industry News

Medtronic CoreValve System Receives FDA Approval for Patients at High Risk for Surgery

June 12, 2014

News Daily News

Treatment Delays May Undermine TAVR Efficacy

June 11, 2014

Presentation TVT 2014

TAVI in A Bicuspid Aortic Valve Stenosis With Edwards Sapien 3 In A Thrilling Scenario

Presenter: Caterina Gandolfo

June 06, 2014

Presentation TVT 2014

2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

Presenter: Catherine M. Otto

June 05, 2014

News Industry News

JENAVALVE ANNOUNCES FIRST IMPLANTATION OF TRANSAPICAL TAVI SYSTEM IN SWEDEN

June 04, 2014

News Industry News

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

June 04, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

L.A. McKeown

May 23, 2014

News Conference News EuroPCR 2014

UK Registry Finds Long-Term Survival After TAVR Depends on Patient Characteristics

Caitlin E. Cox

May 22, 2014

News Industry News

DIRECT FLOW MEDICAL® TRANSCATHETER AORTIC VALVE SYSTEM DEMONSTRATES EXCELLENT 12 MONTH OUTCOMES IN DISCOVER CE MARK TRIAL

May 22, 2014

Advertisement

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

Patient Traits Predict Need for Permanent Pacemaker After TAVR

Los Rasgos del Paciente Predicen la Necesidad de Implantación de un Marcapasos Permanente Post-TAVR

Predictors of Permanent Pacemaker in Patients with Severe Aortic Stenosis Undergoing TAVR

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

Sapien XT Given Go-Ahead to Make US Debut

Sapien XT Aprobado; Hará su Aparición en EE.UU.

CoreValve Approved for TAVR in High-Risk Patients

Edwards Lifesciences Launching SAPIEN XT Valve in the U.S.

Medtronic CoreValve System Receives FDA Approval for Patients at High Risk for Surgery

Treatment Delays May Undermine TAVR Efficacy

TAVI in A Bicuspid Aortic Valve Stenosis With Edwards Sapien 3 In A Thrilling Scenario

2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

JENAVALVE ANNOUNCES FIRST IMPLANTATION OF TRANSAPICAL TAVI SYSTEM IN SWEDEN

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

UK Registry Finds Long-Term Survival After TAVR Depends on Patient Characteristics

DIRECT FLOW MEDICAL® TRANSCATHETER AORTIC VALVE SYSTEM DEMONSTRATES EXCELLENT 12 MONTH OUTCOMES IN DISCOVER CE MARK TRIAL

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content